Limited Research Offer — 10% Automatic discount

New Peptides, Updated COAs & Illumineuro Clearance — Grail Formula Update

Grail Formula continues to expand and refine its peptide lineup, with new product releases, updated analytical reports, and a limited clearance opportunity on Illumineuro Blend.

🧬 New Peptides Now Available

The research catalog has been expanded with the following compounds:

AHK-Cu 100 mg, DiSip 10 mg, GF-AMY 5 mg, Sermorelin 5 mg,
PNC-27 30 mg, Pinealon 10 mg, N-Acetyl Epitalon 20 mg,
Abaloparatide 3 mg, and AICAR 50 mg.

All products are manufactured according to Grail Formula Quality Standards and are independently tested by Liquilabs (Czechia), with full COA documentation confirming purity and batch integrity.

📊 Updated Batches (New COAs)

Several products are now available with new analytical reports, including:

MOTS-C 20 mg, Melanotan 1, and KLOW.

Each batch has been independently verified and includes updated COAs, ensuring consistency and transparency across the lineup.

🔥 Illumineuro Blend — Limited Clearance

A limited number of units from the current Illumineuro Blend batch remain available.

To prepare for the upcoming batch release, these units are offered at:

€109 (previously €159)

There is no difference in quality — all units are fully tested, verified, and supplied with COA documentation.

The new Illumineuro batch, featuring updated analytical verification, will be released once current stock is sold out. Pricing will then return to €159.

🎯 10% Storewide Discount

With rising global costs affecting production and logistics, a 10% discount across the full assortment remains active.

This temporary measure is intended to maintain accessibility, while all products continue to meet strict quality and verification standards.

Grail Formula stands for precision, transparency, and verified quality.

For research use only — not for human or veterinary use.

Newsletter

Social Share